Amylyx Pharmaceuticals, Inc. (AMLX) Technical Analysis
$6.42▲0.16%
Market is closed - opens 7 PM, 02 Jul 2025
Insights
- Amylyx Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Amylyx Pharmaceuticals stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Amylyx Pharmaceuticals stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Amylyx Pharmaceuticals stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 65.95 | Sell |
Stochastic | 85.53, 85.18 | Neutral |
Ultimate Oscillator | 61.85 | Neutral |
Stochastic Relative Strength Index | 87.43, 89.68 | Sell |
Moving Average Convergence Divergence | 0.35, 0.25 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 5.79 | Buy |
20 | 5.55 | Buy |
50 | 5.17 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 5.96 | Buy |
20 | 5.66 | Buy |
50 | 5.15 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 6.09 | Buy |
20 | 5.91 | Buy |
50 | 5.45 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 6.34 | Buy |
20 | 6.1 | Buy |
50 | 5.81 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 6.49 | Buy |
20 | 6.25 | Buy |
50 | 6.04 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 7.1 |
Resistance L2 | 6.84 |
Resistance L1 | 6.59 |
Pivot Point | 6.33 |
Support L1 | 6.08 |
Support L2 | 5.82 |
Support L3 | 5.57 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.